NCT06079151Not yet recruiting

Hemodynamic Effect of Nasal High-flow in Patients Suspected or Followed for a Precapillary Pulmonary Hypertension

Name: Clinical Trial NCT06079151
Creator: ADIR Association
Keywords: Pulmonary Hypertension, Nasal high-flow, device, clinical trial

Physiological Evaluation of the Hemodynamic Effects of Nasal High Flow in Patients Being Explored by Right Heart Catheterisation and Echocardiography for Suspected or Followed Precapillary Pulmonary Hypertension

ADIR AssociationClinicalTrials.govdeviceDevice trial

Verified

Study focus

Disease/Condition: Pulmonary Hypertension
Drug/Device/Intervention: Nasal high-flow
Study type: Interventional
Intervention type: device

Sponsor & location

Primary sponsor: ADIR Association

Timeline & enrollment

Phase: N/A
Start date: Dec 01, 2023
End date: Nov 30, 2025
Enrollment: 20 participants

Primary outcome

Cardiac output

Summary

In this study, the investigators aim to describe the hemodynamic consequences of nasal high-flow measured during right heart catheterization and echocardiography. The research hypothesis is that nasal high-flow would increase cardiac output in patients with pulmonary hypertension. The concomitant echocardiography will allow to describe its sensibility to detect cardiovascular consequences of nasal high-flow.

ICD-10 classifications

Primary pulmonary hypertensionOther secondary pulmonary hypertensionPulmonary heart disease and diseases of pulmonary circulationPulmonary heart disease, unspecifiedPulmonary valve disorders

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06079151
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT06079151 through Pure Global AI's free database. This phase not specified trial is sponsored by ADIR Association and is currently Not yet recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.